ABSTRACT
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The objectives of the present study were to 1) define telemedicine utilization rates during and after the initial height of the COVID-19 lockdown period and 2) determine patient satisfaction with telemedicine during and after the initial height of the COVID-19 lockdown period for spine patients at an orthopedic specialty hospital. SUMMARY OF BACKGROUND DATA: Previous studies have shown high patient satisfaction with telemedicine during the initial height of the COVID-19 pandemic. However, there exists limited data about spine telemedicine utilization and patient satisfaction after the reopening of in-person office visits and easing of restrictions on elective surgical care. METHODS: All patients who had an in-person or telemedicine visit at an urban tertiary specialty hospital from April 1, 2020 to April 15, 2021 were identified. Rates of overall telemedicine utilization over time were delineated. Patient satisfaction with telemedicine, as assessed through a series of questionnaires, was also evaluated over time. RESULTS: Overall, 60,368 patients were identified. Of these, 19,568 patients (32.4%) had a telemedicine visit. During the peak initial coronavirus lockdown period, rate of overall telemedicine utilization on average was greater than 90%. After the peak period, the rate of overall telemedicine utilization on average was at approximately 29% of all visits per month. The percentage of patients who would have been definitely comfortable if the telemedicine visit had been in-person increased over the entire study period (P<0.001). Despite this, patient satisfaction based on survey responses remained statistically similar throughout the study period (P>0.05). CONCLUSION: The rate of telemedicine utilization in spine patients remains high, at approximately 1/3 of all visits, even after the initial peak coronavirus lockdown period. In addition, patient satisfaction with telemedicine remained consistent throughout the study period, regardless of pandemic restrictions on in-person visits. LEVEL OF EVIDENCE: III.